Related Experiment Video
Updated: Apr 1, 2026
04:24
Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
Published on: September 5, 2025
1.4K
Exploring the Impact of Financial Toxicity in COPD: A Qualitative Study
Sonal G Mallya1, Kaila Holloway2, Cyd K Eaton3
1Division of Pulmonary and Critical Care Medicine, Johns Hopkins Medicine, Baltimore, Maryland, United States.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)
|March 30, 2026
Summary
Financial toxicity, the burden of medical costs, is common in chronic obstructive pulmonary disease (COPD). It negatively impacts self-management and well-being, requiring further research and interventions.
Area of Science:
- Pulmonary Medicine
- Health Economics
- Patient-Reported Outcomes
Background:
- Chronic Obstructive Pulmonary Disease (COPD) incurs significant direct and indirect medical costs.
- Financial toxicity, encompassing the burden and distress from medical costs, is understudied in COPD patients.
- Understanding patient experiences is crucial for addressing unique challenges in this population.
Purpose of the Study:
- To investigate the prevalence and impact of financial toxicity in individuals diagnosed with COPD.
- To explore the lived experiences of financial toxicity among COPD patients.
Main Methods:
- Conducted semi-structured interviews with 30 individuals diagnosed with COPD.
- Utilized inductive coding and thematic analysis for transcript analysis by two independent coders.
Main Results:
- Key themes identified include sources of financial burden, adjustments in disease management (e.g., medication nonadherence), financial planning changes, emotional distress, and healthcare communication.
- Participants reported significant material burdens, treatment compromises, and disruptions to financial stability.
- Demographics: 56% female, 43% non-Hispanic White, 43% non-Hispanic Black, mean age 69.5, 70% with public insurance only.
Conclusions:
- This study is the first to describe financial toxicity in COPD, revealing it to be a common issue.
- Financial toxicity in COPD can negatively affect self-management, financial stability, and psychological well-being.
- Further research is needed to assess its impact on patient-reported outcomes and to develop effective interventions.
More Related Videos
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
4.1K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.1K
01:24Chronic Obstructive Pulmonary Disease
3.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.2K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.4K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.4K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
5.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
5.1K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
4.1K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.1K
01:20COPD: Pathogenesis and Clinical Features
2.2K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.2K